Protara Therapeutics (TARA) Non Operating Income (2013 - 2026)

Protara Therapeutics' Non Operating Income history runs 14 years deep, the most recent figure standing at $1.8 million for Q1 2026.

• In Q1 2026, Non Operating Income fell 16.43% year-over-year to $1.8 million; the TTM figure through Mar 2026 stood at $6.7 million (up 12.23% YoY), while the FY2025 annual figure was $7.1 million, up 55.99% from the prior year.
• Non Operating Income was $1.8 million for Q1 2026 at Protara Therapeutics, up from $1.8 million in the prior quarter.
• In the past five years, Non Operating Income ranged from a high of $2.2 million in Q1 2025 to a low of $119000.0 in Q1 2022.
• Historically, Non Operating Income has averaged $1.0 million across 5 years, with a median of $846000.0 in 2023.
• The sharpest annual moves came in 2022 and 2026: Non Operating Income jumped 1560.0% in 2022, then retreated 16.43% in 2026.
• A 5-year view of Non Operating Income shows it stood at $542000.0 in 2022, then soared by 51.29% to $820000.0 in 2023, then soared by 88.17% to $1.5 million in 2024, then climbed by 14.84% to $1.8 million in 2025, then grew by 4.23% to $1.8 million in 2026.
• The last three Non Operating Income figures came in at $1.8 million (Q1 2026), $1.8 million (Q4 2025), and $1.5 million (Q3 2025), per Business Quant data.